GlassScriptPhysician profile
Elizabeth T Bonefas
NPI 1154371813
$4,302.42
in general payments reported to CMS, 2019-2025
20 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $1,136 · 2021: $696 · 2022: $1,097 · 2023: $465 · 2024: $271 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $1,307.65 | 2020-2025 | Savi Scout |
| Endomagnetics LTD | $954.24 | 2021-2024 | Magseed, Magtrace |
| Myriad Genetic Laboratories, INC. | $723.56 | 2021-2024 | Myrisk |
| Biom'Up Sa | $262.85 | 2019 | |
| Ethicon US, LLC | $209.25 | 2022-2024 | Echelon Flex, Enseal, Ethicon |
| Biom'Up France Sas | $168.48 | 2020-2021 | |
| Conmed Corporation | $160.64 | 2019-2022 | |
| Stryker Corporation | $147.39 | 2022 | |
| Tela Bio, INC. | $68.67 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Wound Management Technologies, INC | $62.17 | 2019 | |
| Aroa Biosurgery Incorporated | $40.92 | 2024 | |
| Sanara Medtech INC. | $38.14 | 2020 | |
| Axogen | $34.11 | 2021 | |
| Hologic Sales and Service, LLC | $28.12 | 2025 | Magseed |
| Astrazeneca Pharmaceuticals LP | $22.71 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.32 | 2022 | |
| Coopersurgical, INC. | $15.60 | 2024 | Summit Doppler |
| Dilon Technologies, INC. | $15.16 | 2022 | |
| Clovis Oncology, INC. | $12.38 | 2019 | |
| Bioptics, INC. | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Bonefas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.